R Rakesh Kumar π Hard Worker β 28.44K Points π Biopharmaceutics and Pharmacokinetic Q. The occurrence of food in the GI tract can affect the drug bioavailability from an oral drug product. The above give statement is? (A) True (B) False (C) Both of the above (D) None of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) True
R Rakesh Kumar π Hard Worker β 28.44K Points π Biopharmaceutics and Pharmacokinetic Q. When the solvent molecules are entrapped in the crystalline structure of the polymorph, it is called as (A) Pseudo-polymorphism (B) Amorphism (C) Crystallinity (D) All of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) Pseudo-polymorphism
P Praveen Singh π Tutor III β 36.81K Points π Biopharmaceutics and Pharmacokinetic Q. To avoid bioavailability issues, the drug must have a minimum aqueous solubility of (A) 150% (B) 10% (C) 100% (D) 1% ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (D) 1%
P Priyanka Tomar π Tutor III β 35.28K Points π Biopharmaceutics and Pharmacokinetic Q. ................mechanism is useful to describe charged or highly ionized drug molecules. (A) Ion-pair transport (B) Cellular transport (C) Active transport (D) Passive tr ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) Ion-pair transport
P Praveen Singh π Tutor III β 36.81K Points π Biopharmaceutics and Pharmacokinetic Q. The concentration of drug in blood or plasma will be comparatively in the GI tract. (A) High (B) Low (C) Very High (D) Very Low ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) High
R Ranjeet π Tutor III β 34.60K Points π Biopharmaceutics and Pharmacokinetic Q. ……………… involves the engulfment of small molecules or fluid. (A) Endocytosis (B) Pinocytosis (C) Phagocytosis (D) None of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (B) Pinocytosis
R Ram Sharma π Coach β 193.88K Points π Biopharmaceutics and Pharmacokinetic Q. Energy is utilized in ………………… diffusion mechanism. (A) Passive (B) Active (C) Pore (D) Cellular ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (B) Active
V Vikash Gupta π Tutor III β 33.56K Points π Biopharmaceutics and Pharmacokinetic Q. ………………is the process of movement of unchanged drug from the site of administration to the systemic circulation. (A) Absorption (B) Dissolution (C) Distribution (D) Elimination ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) Absorption
P Priyanka Tomar π Tutor III β 35.28K Points π Biopharmaceutics and Pharmacokinetic Q. Which of the following is alimentary route of administration when passage of drug through liver is minimized? (A) Oral (B) Transdermal (C) Rectal (D) Intraduodenal ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (C) Rectal
P Priyanka Tomar π Tutor III β 35.28K Points π Biopharmaceutics and Pharmacokinetic Q. Which of the following is not the characteristic of the carrier mediated transport system? (A) Energy dependent (B) Reach equilibrium (C) Metabolically inhibited (D) Structurally specific and saturable ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (B) Reach equilibrium